Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) approved KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ ...

FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive first-line Keytruda.

Allied Market Research published a report, titled, "Kidney Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Product and ...

FDA clearance covers pembrolizumab plus paclitaxel ± bevacizumab for PD-L1 CPS ≥1 platinum-resistant disease after one or two prior systemic regimens, introducing PD-1 inhibition into this treatment ...

Peabody resident Shannon Barrios is asking the community to help save her boyfriend’s life. His name is Fernando Candelario, and he needs a kidney transplant. Barrios thought back to November 2021, a ...

The Cancer Action Plan of Washington, or CAPOW, a five-year strategic plan to reduce cancer rates — and cancer deaths — in Washington state just dropped. What action is Fred Hutch taking to drop ...

But now, 13 years after the FDA initially blessed it for skin cancer, the U.S. regulator has approved Keytruda as a second- ...

Tax Day is coming and, according to recent surveys, nearly one third of Americans will procrastinate until the last week to complete and file their 2025 tax returns. The experts at HSA Store® are ...

Zavation Medical Products, LLC ("Zavation"), announces the release of its most advanced cervical interbody implant to ...

WHEN Becki Ward tried but failed to lose weight even after turning to fat jabs, she blamed sheer laziness. After years of ...

Allied Market Research published a report, titled, "Genomics Market by Product (Consumables and Reagent, Services, ...